The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 26, 2020

Filed:

Oct. 14, 2016
Applicant:

University of Florida Research Foundation, Inc., Gainesville, FL (US);

Inventors:

Nicole Alana Horenstein, High Springs, FL (US);

Roger Lee Papke, Gainesville, FL (US);

Marta Quadri, Vigano, IT;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/10 (2006.01); C07D 211/58 (2006.01); C07D 211/70 (2006.01); C07D 295/037 (2006.01); C07D 295/073 (2006.01); C07D 295/155 (2006.01); A61K 31/495 (2006.01); A61K 31/499 (2006.01); A61K 31/452 (2006.01); A61K 31/42 (2006.01); C07D 295/096 (2006.01);
U.S. Cl.
CPC ...
C07D 471/10 (2013.01); A61K 31/42 (2013.01); A61K 31/452 (2013.01); A61K 31/495 (2013.01); A61K 31/499 (2013.01); C07D 211/58 (2013.01); C07D 211/70 (2013.01); C07D 295/037 (2013.01); C07D 295/073 (2013.01); C07D 295/096 (2013.01); C07D 295/155 (2013.01);
Abstract

Derivatives of N,N-diethyl-N'-phenyl-piperazine, a silent agonist of the mammalian α7 nicotinic acetylcholine receptor, are provided. These silent agonists control the desensitization state of the receptor. Further provided are pharmaceutical compositions that allow the administration of the silent agonists of the disclosure to a subject animal or human in need of treatment for a pathological condition arising from such as inflammation. The novel silent agonists also may be co-administered to a patient simultaneously or consecutively with a type II positive allosteric modulator to modulate the activity of the receptor.


Find Patent Forward Citations

Loading…